Our latest technology, Capryl-Butyrate, is changing the game in the exogenous ketone space as it is versatile enough to support both ketogenic and non-ketogenic lifestyles. It facilitates endogenous ...

Reducing glucocorticoid use in the treatment of giant cell arteritis and polymyalgia rheumatica — due to the steroid’s host ...

Scientists modify the genes of bacteria and cells in a lab and use those living organisms to make biologic drugs. The FDA has approved these four biologics to treat atopic dermatitis: dupilumab ...

BioLogic Pharma Solutions aims to be the trusted partner for companies handling complex drug development and commercialization pathways.

The TSXV serves as a vital platform for early-stage, high-growth companies, providing access to capital and a strong investor network. In 2024, 80% of the TSXV Venture 50™ companies operated ...

In recent years, there's been a revolution in Disease-Modifying Antirheumatic Drugs, known as DMARDs, available to control RA, driven largely by biologic therapies. What are these agents ...

Thus, it turns out that both sides in an earlier debate about biosimilars' impact on the biologic drug market were correct. In 2017, at the American College of Rheumatology's annual meeting ...

Biologic medicines have transformed treatment for numerous chronic and life-threatening conditions such as cancer, ...

Human antibodies take center stage, as they pile up in the list of approved biologics in 2009. Cormac Sheridan reports. Last year was a vintage year for the bio-pharmaceutical industry in two ...